Thursday, July 5, 2018

(Reuters Health) - Many breast cancer patients may miss out on genetic tests that could help pinpoint the ideal treatment regimen at least in part because their surgeons are uncomfortable discussing the pros and cons of these tests, a U.S. study suggests.


from Reuters: Health News https://ift.tt/2lSdPlD

Related Posts:

  • LATEST HEALTH NEWSHeart transplant surgery is a rare facility available in the country, and no reliable data is available on transplant outcomes of the few facilities in existence from Health https://ift.tt/2REqd74 … Read More
  • LATEST HEALTH NEWS'What you don't want to do is use therapy where it brings no value to patients, adds to cost and doesn't lead to better results,' said Joseph Alvarnas, a hematologist oncologist at City of Hope in Dua from Health https://ift… Read More
  • LATEST HEALTH NEWSThe researchers studied fingernail photos and correlated the colour of the fingernail beds with hemoglobin levels to develop the apps algorithm from Health https://ift.tt/2E61zbB … Read More
  • LATEST HEALTH NEWSHe Jiankui had told a packed biomedical conference he was 'proud' to have successfully altered the DNA of twin girls born to an HIV-positive father from Health https://ift.tt/2KFLL08 … Read More
  • LATEST HEALTH NEWSCare has just collapsed into treatment, people need more than just treatment and medication when we are talking about care. from Health https://ift.tt/2zyy5zE … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner